Physician profile
Gregory B Mecoli
NPI 1053613844
$2,221.40
in general payments reported to CMS, 2019-2025
16 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $57.25 · 2021: $59.24 · 2022: $161 · 2023: $195 · 2024: $127 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,516.26 | 2019-2025 | Clareon, Simbrinza, Centurion |
| Abbvie INC. | $118.61 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.61 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $70.31 | 2019-2025 | Tecnis Iol |
| Regeneron Healthcare Solutions, INC. | $66.81 | 2023 | Eylea, Eylea Hd |
| Novartis Pharmaceuticals Corporation | $66.14 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $63.64 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $42.15 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $37.55 | 2019 | |
| Aerie Pharmaceuticals, INC. | $32.13 | 2019 | |
| Lombart Brothers, INC. | $30.27 | 2019 | |
| Astellas Pharma US INC | $25.69 | 2025 | Izervay |
| Shire North American Group INC | $22.98 | 2019 | |
| Bausch & Lomb Americas INC. | $20.57 | 2022 | |
| Alimera Sciences, INC. | $15.94 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $15.74 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mecoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.